Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. (300501.SZ)
CNY 14.03
(0.29%)
CNY 14.03
(0.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 141.67 Million | 136.95 Million | 139.63 Million | 77.48 Million | 95.87 Million | 27.48 Million |
| Net Income | 85.44 Million | 109.85 Million | 109.02 Million | 105.42 Million | 65.73 Million | 64.36 Million |
| Depreciation & Amortization | 57.22 Million | 45.91 Million | 37.06 Million | 34.59 Million | 33.04 Million | 22.21 Million |
| Deferred income taxes | -2.35 Million | -5.82 Million | -5.04 Million | -2.6 Million | -620.77 Thousand | 662.24 Thousand |
| Stock-based compensation | - | - | 1.36 Million | 4.65 Million | 13.2 Million | 486.48 Thousand |
| Change in working capital | -76.65 Million | -19.9 Million | -2.96 Million | -66.18 Million | -12.38 Million | -59.08 Million |
| Other non-cash items | 269.13 Million | 1.09 Million | -3.49 Million | 3.64 Million | 9.48 Million | -79.14 |
| Investing Cash Flow | -326.98 Million | -336.98 Million | -248.67 Million | -112.87 Million | -195.73 Million | -100.84 Million |
| Investments in PPE | -298.82 Million | -347.13 Million | -241.64 Million | -138.67 Million | -83.28 Million | -67.68 Million |
| Acquisitions | 2.23 Million | 1.09 Million | 1.76 Million | 138.69 Million | 144.42 Thousand | -55.19 Million |
| Investment purchases | -188.05 Million | -424.19 Million | -230.49 Million | -495.66 Million | -239.59 Million | -570.15 Million |
| Sales/Maturities of investments | 157.65 Million | 433.25 Million | 221.69 Million | 521.44 Million | 111.1 Million | 591.49 Million |
| Other Investing Activities | 1.00 | 1.12 | 1.08 | -138.67 Million | 15.89 Million | 690.28 Thousand |
| Financing Cash Flow | 585.65 Million | -117.09 Million | 653.49 Million | 53.37 Million | 120.57 Million | -8.01 Million |
| Debt repayment | -610.22 Million | -225.69 Million | -252.03 Million | -140.32 Million | -49.82 Million | -6.5 Million |
| Dividends payments | -6.24 Million | -23.05 Million | -7.67 Million | -7.67 Million | -30.26 Million | -34.8 Million |
| Common Stock Repurchased | - | - | -973.8 Thousand | - | -29.69 Million | - |
| Common Stock Issuance | - | - | 973.8 Thousand | - | 29.69 Million | - |
| Other Financing Activities | -15.14 Million | 144.35 Million | 928.25 Million | 212.17 Million | 206.81 Million | 33.28 Million |
| Accounts receivables | -47.28 Million | -102.42 Million | -2.13 Million | -43.16 Million | -81.12 Million | -76.69 Million |
| Accounts payables | -13.91 Million | 124.5 Million | 50.17 Million | -15.06 Million | 79.29 Million | 39.78 Million |
| Inventory | -15.45 Million | -36.16 Million | -45.96 Million | -5.34 Million | -9.93 Million | -22.84 Million |
| Other working capital | -1.00 | -5.82 Million | -5.04 Million | -2.6 Million | -620.77 Thousand | -36.24 Million |
| Cash at beginning of period | 320.86 Million | 613.46 Million | 70.6 Million | 55.15 Million | 34.74 Million | 115.54 Million |
| Cash at end of period | 705.51 Million | 302.09 Million | 613.46 Million | 70.6 Million | 55.15 Million | 34.74 Million |
| Capital Expenditure | -298.82 Million | -347.13 Million | -241.64 Million | -138.67 Million | -83.28 Million | -67.68 Million |
| Effect of forex changes on cash | 2.82 Million | 5.75 Million | -1.6 Million | -2.53 Million | -305.49 Thousand | 572.88 Thousand |
| Net cash flow / Change in cash | 384.64 Million | -311.36 Million | 542.85 Million | 15.44 Million | 20.41 Million | -80.79 Million |
| Free Cash Flow | -157.14 Million | -210.18 Million | -102 Million | -61.18 Million | 12.58 Million | -40.19 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 21.86 Million | 34.84 Million | 23.01 Million | -5.59 Million | 85.44 Million | 48.11 Million |
| Depreciation & Amortization | - | 15.57 Million | 15.57 Million | 14.3 Million | 57.22 Million | 14.3 Million |
| Deferred income taxes | - | - | - | - | -2.35 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -138.09 Million | - | -62.74 Million | -76.65 Million | -10.9 Million |
| Other non-cash items | 126.13 Million | -8.32 Million | -49.8 Million | 191.36 Million | 269.13 Million | -47.78 Million |
| Investing Cash Flow | -166.47 Million | -55.56 Million | -17.84 Million | -14.96 Million | -326.98 Million | -54.03 Million |
| Investments in PPE | -25.63 Million | -43.07 Million | -69.55 Million | -26.07 Million | -298.82 Million | -57.7 Million |
| Acquisitions | 86.92 Thousand | - | 16.1 Thousand | 2.11 Million | 2.23 Million | 12.27 Thousand |
| Investment purchases | -313.93 Million | -34.49 Million | -42.5 Million | -79.05 Million | -188.05 Million | -1 Million |
| Sales/Maturities of investments | 173 Million | 22 Million | 94.2 Million | 88.05 Million | 157.65 Million | 4.65 Million |
| Other Investing Activities | 86.92 Thousand | -12.42 Million | 52.04 Million | 42.08 Million | 1.00 | 0.60 |
| Financing Cash Flow | -116.18 Million | -72.06 Million | -36.41 Million | -2.48 Million | 585.65 Million | -56.7 Million |
| Debt repayment | -105 Million | -9.8 Million | -26.46 Million | -637.02 Million | -610.22 Million | -65.68 Million |
| Dividends payments | -6.5 Million | -30.74 Million | -10.5 Million | -6.24 Million | -6.24 Million | -9.67 Million |
| Common Stock Repurchased | - | -54.86 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.68 Million | -81.86 Million | -9.94 Million | -630.08 Million | -15.14 Million | 11.45 Million |
| Accounts receivables | - | -113.64 Million | - | -47.28 Million | -47.28 Million | -10 Million |
| Accounts payables | - | - | - | - | -13.91 Million | - |
| Inventory | - | -24.45 Million | - | -15.45 Million | -15.45 Million | -903.17 Thousand |
| Other working capital | - | - | - | - | -1.00 | - |
| Cash at beginning of period | 508.16 Million | 628.51 Million | 705.51 Million | 586.6 Million | 320.86 Million | 689.37 Million |
| Cash at end of period | 370.07 Million | 519.65 Million | 628.51 Million | 705.51 Million | 705.51 Million | 586.48 Million |
| Capital Expenditure | -25.63 Million | -43.07 Million | -69.55 Million | -26.07 Million | -298.82 Million | -57.7 Million |
| Effect of forex changes on cash | -3.17 Million | 449.2 Thousand | 191.53 Thousand | -1.11 Million | 2.82 Million | 3741.67 |
| Net cash flow / Change in cash | -138.08 Million | -108.85 Million | -76.99 Million | 118.9 Million | 384.64 Million | -102.88 Million |
| Free Cash Flow | 122.36 Million | -32.13 Million | -96.34 Million | 111.26 Million | -157.14 Million | -53.97 Million |
IPO
LUXHP
ORZCF
AMBP
APLE
HNST